Found 8 matching trials
Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma
PHASE1This will be a Phase 1, open-label study to evaluate the safety and efficac...
Location
Children's Hospital of Philadelphia
CD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Label Study
PHASE1Phase I was a single arm, open label, dose increasing study to explore the ...
Location
First Affiliated Hospital of Zhengzhou University
Cell Therapy for CD7 Positive Acute Myeloid Leukemia or Mixed Lineage Leukemia
NAThis is an open, single-arm, clinical study to evaluate efficacy and safety...
Location
He bei Yan da Lu dao pei Hospital
SupCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies
PHASE1The aim of this study was to evaluate the safety and efficacy of supCD7 CAR...
Location
Institute of Hematology & Blood Diseases Hospital
Clinical Study of the Safety and Efficacy of ASCT Combined With CD7-CART in the Treatment of CD7+ TCL
PHASE2To evaluate the safety and efficacy of autologous hematopoietic stem cell t...
Location
Blood Disease Hospital, Chinese Academy of Medical Sciences
uCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies
PHASE1The aim of this study was to evaluate the safety and efficacy of universal ...
Location
Institute of Hematology & Blood Diseases Hospital
Clinical Study of Senl-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ Acute T-ALL/T-LBL
NAThis is an open, prospective, dose-escalation clinical study to evaluate th...
Location
Hebei yanda Hospital
CD7 CAR-T Cell Therapy Targeting CD7-positive Relapsed/Refractory T Cell Lymphoma/Acute Leukemia
NACD7 molecules are thought to be associated with disease aggressiveness, dru...
Location
Multiple Locations